Shares in Shanghai Fosun Pharmaceutical tumbled as much as 12 per cent on their Hong Kong market debut on Tuesday, suggesting a rough ride ahead for Zhengzhou Coal Mining Machinery, the People’s Insurance Company of China and other Chinese groups still hoping to raise money this year.
复星医药(Fosun Pharmaceutical)周二在香港股市交易首日，盘中股价一度下跌12%。这预示着，包括郑州煤矿机械集团(Zhengzhou Coal Mining Machinery)、manbetx3.0 人保(PICC)等数家仍希望于年内在香港融资的中资集团将面临不平坦的上市之路。
您已阅读11%（425字），剩余89%（3446字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。